Keywords
InterimEarly stoppingSubgroup analysisInterim analysisMultiplicity (mathematics)EconometricsMedicineStatisticsClinical trialPsychologyMathematicsComputer scienceArtificial intelligenceConfidence intervalLawInternal medicinePolitical science
Affiliated Institutions
Related Publications
Statistical Problems in the Reporting of Clinical Trials
Reports of clinical trials often contain a wealth of data comparing treatments. This can lead to problems in interpretation, particularly when significance testing is used exten...
Interim analysis: The alpha spending function approach
Abstract Interim analysis of accumulating data in a clinical trial is now an established practice for ethical and scientific reasons. Repeatedly testing interim data can inflate...
Investigating patient exclusion bias in meta-analysis
Trials, systematic reviews, and meta-analyses may be prone to bias associated with post-randomization exclusion of patients. Wherever possible, the level of such exclusions shou...
Systematic reviews in health care: Assessing the quality of controlled clinical trials
This is the first in a series of four articles The quality of controlled trials is of obvious relevance to systematic reviews. If the “raw material” is flawed then the conclus...
Meta-analysis for the evaluation of potential surrogate markers
We describe a meta-analysis approach for the evaluation of a potential surrogate marker. Surrogate markers are useful in helping to identify therapeutic mechanisms of action and...
Publication Info
- Year
- 2005
- Type
- article
- Volume
- 365
- Issue
- 9471
- Pages
- 1657-1661
- Citations
- 355
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
355
OpenAlex
Cite This
Kenneth F. Schulz,
David A. Grimes
(2005).
Multiplicity in randomised trials II: subgroup and interim analyses.
The Lancet
, 365
(9471)
, 1657-1661.
https://doi.org/10.1016/s0140-6736(05)66516-6
Identifiers
- DOI
- 10.1016/s0140-6736(05)66516-6